Found 243 matching trials
PEP-CMV Vaccine Targeting CMV Antigen to Treat Newly Diagnosed Pediatric HGG and DIPG and Recurrent Medulloblastoma PHASE2 This study will address the question of whether targeting CMV antigens with...
Show More Location
Children's Hospital Colorado
Learn More & Join Trial
Immunotherapy of Melanoma Patients PHASE1 The purpose of this study is to test whether vaccination with antigenic pep...
Show More Location
Ludwig Institute for Cancer Research + Multidisciplinary Oncology Center at the Centre Hospitalier Universitaire Vaudois
Learn More & Join Trial
A Pilot Study of Vaccination With Epitope-Enhanced TARP Peptide and TARP Peptide-Pulsed Dendritic Cells in the Treatment of Stage D0 Prostate Cancer PHASE1 Background:
* PSA (prostate specific antigen) is a protein found on normal...
Show More Location
National Institutes of Health Clinical Center, 9000 Rockville Pike
Learn More & Join Trial
A Phase II Trial of Neoadjuvant PD-1 Vaccine PD1-Vaxx in Operable MSI High Colorectal Cancer PHASE2 The aim of Neo-POLEM is to determine the rate of Major Pathological Respons...
Show More Location
The Queen Elizabeth Hospital
Learn More & Join Trial
IDO Peptid Vaccination for Stage III-IV Non Small-cell Lung Cancer Patients. PHASE1 Title: IDO peptid vaccination in combination with immune stimulating agent ...
Show More Location
Center for Cancer ImmuneTherapy
Learn More & Join Trial
Testing the SurVaxM Vaccine for Lung Cancer Prevention PHASE2 This phase II trial tests how well a survivin peptide vaccine called SurVax...
Show More Location
Rocky Mountain Regional VA Medical Center
Learn More & Join Trial
A Trial to Evaluate the Safety, Reactogenicity, and Immunogenicity of MVA-BN Yellow Fever Vaccine With and Without Montanide ISA-720 Adjuvant in 18-45 Year Old Healthy Volunteers PHASE1 This study is a multi-center, double-blind, placebo-controlled, Phase I stu...
Show More Location
University of Iowa - Vaccine Research and Education Unit
Learn More & Join Trial
A Phase I/II Trial to Evaluate a Peptide Vaccine Plus Ipilimumab in Patients With Melanoma PHASE1 This study evaluates whether it is safe to administer a peptide vaccine wit...
Show More Location
Cancer Center at the University of Virginia
Learn More & Join Trial
A Pilot Study of NY-ESO-1b Peptide Plus CpG 7909 and Montanide® ISA-51 in Patients With Cancer. PHASE1 This cancer vaccine research study involves the injection of the NY-ESO-1b ...
Show More Location
Krankenhaus Nordwest
Learn More & Join Trial
Safety Study of Adjuvant Vaccine to Treat Melanoma Patients PHASE1 The incidence of melanoma is increasing with an estimated incidence of 59,9...
Show More Location
New York University Langone Medical Center
Learn More & Join Trial